176 related articles for article (PubMed ID: 14751286)
1. TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.
Danoff SK; Taylor HE; Blackshaw S; Desiderio S
Neuroscience; 2004; 123(4):931-8. PubMed ID: 14751286
[TBL] [Abstract][Full Text] [Related]
2. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
[TBL] [Abstract][Full Text] [Related]
3. Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23.
Hirota H; Matsuoka R; Chen XN; Salandanan LS; Lincoln A; Rose FE; Sunahara M; Osawa M; Bellugi U; Korenberg JR
Genet Med; 2003; 5(4):311-21. PubMed ID: 12865760
[TBL] [Abstract][Full Text] [Related]
4. TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.
Ohazama A; Sharpe PT
Dev Dyn; 2007 Oct; 236(10):2884-8. PubMed ID: 17823943
[TBL] [Abstract][Full Text] [Related]
5. Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.
Lazebnik MB; Tussie-Luna MI; Hinds PW; Roy AL
J Biol Chem; 2009 Dec; 284(52):36234-36239. PubMed ID: 19880526
[TBL] [Abstract][Full Text] [Related]
6. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
7. Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes.
Meng X; Lu X; Li Z; Green ED; Massa H; Trask BJ; Morris CA; Keating MT
Hum Genet; 1998 Nov; 103(5):590-9. PubMed ID: 9860302
[TBL] [Abstract][Full Text] [Related]
8. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.
Tipney HJ; Hinsley TA; Brass A; Metcalfe K; Donnai D; Tassabehji M
Eur J Hum Genet; 2004 Jul; 12(7):551-60. PubMed ID: 15100712
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic diagnosis of Williams syndrome.
Hirota H; Matsuoka R; Kimura M; Imamura S; Joh-o K; Ando M; Takao A; Momma K
Am J Med Genet; 1996 Aug; 64(3):473-7. PubMed ID: 8862624
[TBL] [Abstract][Full Text] [Related]
11. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
12. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
[TBL] [Abstract][Full Text] [Related]
13. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
14. A novel human gene FKBP6 is deleted in Williams syndrome.
Meng X; Lu X; Morris CA; Keating MT
Genomics; 1998 Sep; 52(2):130-7. PubMed ID: 9782077
[TBL] [Abstract][Full Text] [Related]
15. Variability of the cranial and dental phenotype in Williams syndrome.
Axelsson S
Swed Dent J Suppl; 2005; (170):3-67. PubMed ID: 15762376
[TBL] [Abstract][Full Text] [Related]
16. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
17. Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.
Hinsley TA; Cunliffe P; Tipney HJ; Brass A; Tassabehji M
Protein Sci; 2004 Oct; 13(10):2588-99. PubMed ID: 15388857
[TBL] [Abstract][Full Text] [Related]
18. Williams syndrome: from genotype through to the cognitive phenotype.
Donnai D; Karmiloff-Smith A
Am J Med Genet; 2000; 97(2):164-71. PubMed ID: 11180224
[TBL] [Abstract][Full Text] [Related]
19. Divergent human and mouse orthologs of a novel gene (WBSCR15/Wbscr15) reside within the genomic interval commonly deleted in Williams syndrome.
Doyle JL; DeSilva U; Miller W; Green ED
Cytogenet Cell Genet; 2000; 90(3-4):285-90. PubMed ID: 11124535
[TBL] [Abstract][Full Text] [Related]
20. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
